Hedge Fund - Tybourne Capital Management
Bicycle Therapeutics Plc (BCYC)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2025 - Q1 (2025-03-31) | $4,893,153 | 20.77% | 576,343 | $11.78 |
2 | 2024 - Q4 (2024-12-31) | $17,773,490 | 4.46% | 1,269,535 | $21.43 |
3 | 2024 - Q3 (2024-09-30) | $31,558,328 | 8.84% | 1,394,535 | $23.07 |
4 | 2024 - Q2 (2024-06-30) | $30,556,592 | 6.21% | 1,509,713 | $22.59 |
5 | 2024 - Q1 (2024-03-31) | $38,471,148 | 6.57% | 1,545,026 | $21.24 |
6 | 2023 - Q4 (2023-12-31) | $29,837,786 | 4.44% | 1,650,320 | $16.54 |
7 | 2023 - Q3 (2023-09-30) | $25,751,764 | 3.59% | 1,281,820 | $22.87 |
8 | 2023 - Q2 (2023-06-30) | $32,712,046 | 3.53% | 1,281,820 | $23.23 |
9 | 2023 - Q1 (2023-03-31) | $29,965,835 | 3.01% | 1,408,831 | $25.08 |
10 | 2022 - Q4 (2022-12-31) | $26,809,371 | 2.67% | 905,722 | $26.83 |
11 | 2022 - Q3 (2022-09-30) | $24,221,000 | 2.32% | 1,041,331 | $23.79 |
12 | 2022 - Q2 (2022-06-30) | $19,366,000 | 1.39% | 1,154,126 | $21.09 |
13 | 2022 - Q1 (2022-03-31) | $50,643,000 | 2.99% | 1,154,126 | $46.70 |
14 | 2021 - Q4 (2021-12-31) | $125,015,000 | 3.71% | 2,053,804 | $55.18 |
15 | 2021 - Q3 (2021-09-30) | $81,432,000 | 2.05% | 1,957,961 | $34.98 |
16 | 2021 - Q2 (2021-06-30) | $59,444,000 | 1.25% | 1,957,961 | $30.21 |
17 | 2021 - Q1 (2021-03-31) | $58,484,000 | 1.28% | 1,957,961 | $25.79 |
18 | 2020 - Q4 (2020-12-31) | $35,145,000 | 0.73% | 1,957,961 | $19.31 |
19 | 2020 - Q3 (2020-09-30) | $37,299,000 | 0.91% | 1,957,961 | $17.66 |
20 | 2020 - Q2 (2020-06-30) | $30,818,000 | 0.93% | 1,957,961 | $15.37 |
21 | 2020 - Q1 (2020-03-31) | $26,726,000 | 0.97% | 1,957,961 | $12.74 |
22 | 2019 - Q4 (2019-12-31) | $18,464,000 | 0.7% | 1,957,961 | $9.06 |
23 | 2019 - Q3 (2019-09-30) | $22,301,000 | 0.96% | 1,957,961 | $8.59 |
24 | 2019 - Q2 (2019-06-30) | $19,697,000 | 0.7% | 1,957,961 | $12.05 |
The displayed share prices are average quarterly stock market prices.